Skip to main content

ORIGINAL RESEARCH article

Front. Neurol., 12 November 2021
Sec. Neuroepidemiology
This article is part of the Research Topic Neuroepidemiology of Stroke in Low and Middle Income Countries View all 9 articles

Cerebrovascular Risk Profiles in a Saudi Arabian Cohort of Young Stroke Patients

  • 1Department of Stroke Medicine, Fairfield General Hospital, Manchester, United Kingdom
  • 2Division of Health Care Sciences, Center for Clinical Research and Management Education, Dresden International University, Dresden, Germany
  • 3Department of Neurology, King Abdullah Medical City, Mecca, Saudi Arabia
  • 4Winnipeg Regional Health Authority (WRHA), Department of Medicine, Section of Neurology, The Max Rady Faculty of Health Sciences, Brandon Regional Health Centre, University of Manitoba, Winnipeg, MB, Canada
  • 5Department of Neurology, Carl Gustav Carus University Hospital, Technische Universität Dresden, Dresden, Germany
  • 6Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States

Background: The constantly increasing incidence of stroke in younger individuals substantiates an urgent need for research to elucidate underlying risk factors and etiologies. Heretofore, the vast majority of studies on stroke in the young have been carried out in European and North American regions. We aimed to characterize cerebrovascular risk profiles in a Saudi Arabic cohort of consecutive young stroke patients.

Methods: We retrospectively analyzed data from consecutive ischemic stroke patients aged 15 to 49 years who underwent detailed cardiocerebrovascular evaluation at a tertiary stroke care center in Makkah, Saudi Arabia. Distributions of risk factors and stroke etiologies were assessed in the entire cohort and in two strata of very young (15–40 years) and young to middle-aged patients (41–49) to account for variability in suggested age cutoffs.

Results: In the entire cohort [n = 63, ages 44 (34–47) median, interquartile range], dyslipidemia (71.4%) and small vessel occlusion (31.7%) displayed highest prevalence followed by diabetes (52.4%) and cardioembolism (19%). In very young patients, cardioembolism was the most prevalent etiology (27.3%). Risk profiles were similar between both age strata except for a higher prevalence of diabetes among the older cohort (31.8 vs. 63.4%, p = 0.01). Logistic regression identified diabetes as strongest predictor for association to the older strata (odds ratio = 4.2, 95% confidence interval = 1.2–14.1, p = 0.02).

Conclusion: Cerebrovascular risk profiles and stroke etiologies in our cohort of young stroke patients differ from those of previous cohorts, suggesting the need for tailored prevention strategies that take into account local epidemiological data on cerebrovascular health.

Introduction

Stroke is the third leading cause of death and a major cause of disability in survivors. More than 65% of stroke-related deaths occur in developing countries (1, 2). While stroke in the elder population has been studied extensively, the distribution of risk factors and stroke etiologies in the young has not been fully elucidated to date. Moreover, there is no clear age cut-off to define young people. However, several studies defined juvenile stroke as stroke that occurs before the age of 50 years. Stroke in individuals younger than 18 years is frequently referred to as pediatric stroke, an entity that is equally understudied (38). Approximately 10% of ischemic strokes occur in this age group (9, 10). The repercussions seen in juvenile stroke are socioeconomically higher than in the elderly because of its devastating disability during highly productive years. Recently, several studies have shown a rise in the incidence of ischemic stroke at younger ages since the 1980s with the concurrent decline of incidence at older ages (1116).

Various studies assessed etiologies and risk factors of stroke in young adults from different countries, the majority of which located in North America or Europe (3, 1730). These studies showed substantial geographic and ethnic differences of cerebrovascular risk profiles and distribution of etiologies of stroke in the young. In the Kingdom of Saudi Arabia, acute stroke is a frequent disorder with an incidence of 30 to 40 per 1,00,000 per year and a prevalence of 186 per 1,00,000. However, the local epidemiology and clinical presentation of stroke in the young are unknown to date (30, 31). Defining patterns of modifiable cerebrovascular risk factors and stroke etiologies in the population of young individuals with acute stroke in this region might help develop tailored preventive strategies to improve cerebrovascular health. Therefore, we sought to characterize cerebrovascular risk profiles in a Saudi Arabic cohort of consecutive juvenile stroke patients.

Materials and Methods

Design, Population, and Protocol

We carried out a retrospective analysis including data on consecutive acute ischemic stroke patients from the electronic medical records data bank of the tertiary stroke center at King Abdullah Medical City (KAMC) in Makkah, Saudi Arabia. Patients aged 15 to 49 years with ischemic stroke at the time of presentation from January 2012 to December 2018 were included. We explicitly chose to include patients younger than 18 years but older than 14 years that would be considered pediatric stroke rather than juvenile stroke to allow an analysis in two age strata of young stroke patients. Thus, we tolerated an overlap between the definition of our very young stroke cohort and common agreement on the definition of pediatric stroke. The main reason for this approach was the arbitrary nature of commonly accepted age cutoffs and our goal to test new age strata that have not been used before. However, this approach later turned out to remain anecdotal as all of our patients were, in fact, older than 18 years. Diagnosis of acute ischemic stroke was done by a stroke neurologist and was confirmed by a neuroradiologist based on cerebral imaging [computed tomography (CT) or magnetic resonance imaging (MRI)]. Patients with hemorrhagic stroke, cerebral venous thrombosis, iatrogenic stroke secondary to a procedure or operation, or transient ischemic attack were excluded. The Trial of Org 10172 in Acute Stroke Treatment criteria was applied to categorize stroke etiologies (32). To assess age-related trends, our study population was dichotomized according to their age into a very young cohort who are 40 years or younger and a young to middle-aged cohort who are 41 to 49 years old. The most common risk factors were explored including demographics, smoking, alcohol, obesity, illicit drugs, family history, hypertension, diabetes mellitus, dyslipidemia, and cardiovascular disease. They were matched to definitions of the Helsinki Young Stroke Registry, which is a large study of ischemic stroke in young adults (3). Thrombophilia screen (including protein C, protein S, antithrombin III, prothrombin mutation gene, and factor V Leiden mutation) and autoimmune profile (including antinuclear antibodies, anti–double-stranded deoxyribonucleic acid antibodies, antineutrophil cytoplasmic antibodies, anticardiolipin antibodies, and lupus anticoagulants), which are routinely requested to young people admitted with stroke, were also included in our analysis.

Cerebrovascular risk profiles and etiologies were further assessed using results of cerebral imaging (cranial CT or MRI) and vessel imaging (CT angiography to head and neck or magnetic resonance time-of-flight angiography of brain vessels combined bilateral carotid Doppler). Accordingly, the vascular territory was classified as anterior circulation, posterior circulation, or both, and stroke location was categorized as the cerebral, cerebellar, brain stem, or multiple. To complement cerebrovascular phenotyping, cardiac tests were undertaken, including transthoracic echocardiography as well as Holter monitoring for 48 h. Transesophageal echocardiography has not yet been established as institutional standard at the time of study commencement and was therefore performed at the discretion of the treating stroke physician.

Ethics

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the institutional review board of KAMC (IRB no. 18-485, date of approval April 24, 2019).

Statistical Analysis

Analysis was performed using SPSS (IBM SPSS Statistics for Windows, version 22.0, released 2013; IBM Corp., Armonk, NY). Available case analysis was carried out. Data are presented as absolute and relative frequencies or median and interquartile range (IQR) according to type and distribution. Age strata, groups of male and female patients, and Saudi and non-Saudi patient groups were compared using Pearson χ2 for categorical variables. A two-sided p < 0.05 was considered significant. Fisher exact test was used whenever needed to confirm results. Additional logistic regression analysis was performed to identify potential predictors for association to either age group.

Results

Study Population

From January 2012 to December 2018, 63 patients younger than 50 years were admitted to KAMC with ischemic stroke. Of these, 43 patients (68.3%) were males, and 20 patients (31.8%) were females. The median age of patients in this study was 44 years (IQR = 34–47 years). There was no difference in gender ratio between the two age groups (males/females: very young: 8/17 vs. 12/26; p = 1.0). Forty-six patients (73.0%) of the population were Saudi, whereas 17 patients (27.0%) were from other nationalities (from Pakistan, Bangladesh, and Yemen). The very young strata of stroke patients aged 15 to 40 years consisted of 25 patients (39.7%), whereas the young to middle-aged strata including stroke patients aged 41 to 49 years comprised 38 patients (60.3%). Etiology results according to Toast classification provided a complete data set.

Cerebrovascular Risk Profiles

Dyslipidemia was the risk factor most frequently seen for stroke in our cohort (71.4%), followed by smoking (52.4%), diabetes mellitus (52.4%) and hypertension (50.8%). The most prevalent risk factor in the very young cohort was dyslipidemia (64%), followed by smoking (52%), whereas in young to middle-aged cohort, dyslipidemia was the most frequent (76.3%), with diabetes mellitus being the second most frequent risk factor (68.4%). In male patients, dyslipidemia was the most frequently found risk factor (79%), followed by smoking (74.4%). Among female patients, both dyslipidemia and obesity displayed highest frequencies (both 55%), followed by diabetes mellitus (45%). Comparing the two-age strata revealed a higher prevalence of diabetes (68.4 vs. 28%, p = 0.001) in the young to middle-aged cohort. Patterns of risk factors among age groups are depicted in Figure 1. On analysis of risk factors by gender, cardiovascular disease was more often present in males (34.9 vs. 5%, p = 0.01) than in females. Risk factor profiles are detailed in Table 1. Logistic regression analysis identified diabetes mellitus as predictor for association to either age group, with the older patients suffering more frequently from diabetes [odds ratio (OR) = 4.2, 95% confidence interval (CI) = 1.2–14.1, p = 0.02]. Distribution of cerebrovascular risk factors in the very young stroke population compared to the young to middle-aged stroke population is depicted in Figure 1.

FIGURE 1
www.frontiersin.org

Figure 1. Distribution of cerebrovascular risk factors in the very young stroke population (A) as compared to the young (B) stroke population.

TABLE 1
www.frontiersin.org

Table 1. Cerebrovascular risk profiles (n = 63).

Juvenile Stroke Etiology

The most frequent stroke etiology in our study population was small vessel occlusion (31.7%), followed by cardioembolism (19%) and large-artery atherosclerosis (12.7%). In the very young strata, cardioembolism and small vessel occlusion were more prevalent (each 24%), whereas in the young to middle-aged strata, small vessel disease was more frequent (36.8%) (Table 2). Cause of cardioembolic strokes comprised intracardiac thrombus (n = 6), ischemic cardiomyopathy (n = 2), dilated cardiomyopathy (n = 1), atrial fibrillation (n = 2), and patent foramen ovale (n = 1). Eleven young stroke patients (17.5%) were categorized as other determined cause of stroke. Diagnostic workup revealed artery dissection (n = 4), rare arterial diseases (n = 3), autoimmune vasculitis (n = 1), hypoperfusion with bilateral watershed infarcts (n = 1), decreased protein S levels (n = 1), and antiphospholipid syndrome with positive test of anticardiolipin antibodies (n = 1). In the patient with antiphospholipid syndrome, test of anticardiolipin antibodies was still positive at repeated testing 3 months later. Twelve patients (19%) had cryptogenic stroke. The prevalence of stroke etiologies did not differ between males and females. On logistic regression, stroke etiology displayed no predictive association with either of the two age strata (very young and young to middle-aged: OR = 1.2, 95% CI = 0.7–1.8, p = 0.5).

TABLE 2
www.frontiersin.org

Table 2. Distribution of stroke etiologies (n = 63).

Vascular Territories

Anterior circulation stroke was noted in 44 patients (69.8 %), whereas 11 patients (17.5%) of our study population had posterior circulation stroke. Eight patients (12.7%) had a stroke in both vascular territories (Table 3). There was no difference between males and females or age strata regarding the vascular territory involved.

TABLE 3
www.frontiersin.org

Table 3. Anatomical distribution of ischemic stroke by circulation territory (n = 63).

Discussion

Our Saudi Arabian cohort showed a distinct pattern of cerebrovascular risks factors and stroke etiologies with highest prevalence for dyslipidemia and small vessel occlusion. Although dyslipidemia has been shown to be a predominant risk factor in multiple cohorts including the large population of young stroke patients of the Helsinki Young Stroke Registry, our observation that the majority of strokes was caused by small vessel disease differs from previously reported cohorts where cervicocephalic arterial dissection and cardioembolism rank among the leading etiologies (33). This underscores the importance of comprehensive regional data on stroke cerebrovascular risk profiles and etiologies in young patients to account for geographic variance and help design targeted prevention strategies.

Subgroup analysis on age, gender, and nationality allowed a more detailed insight in cerebrovascular risk profiles and etiologies of our cohort. Both diabetes and cardiovascular disease were more prevalent in the young to middle-aged strata consistent with the results of the Helsinki Young Stroke Registry (3). On analysis of risk factors by gender, cardiovascular disease was more frequent in males than females, an observation that also shows overall agreement with previous research (3, 34). As ethnic and geographic variance in young stroke patients is well-known, we compared patients of Saudi nationality with the non-Saudi fraction of our cohort. The latter accounted for about a quarter of our study population. However, we did not observe any differences between these two groups, likely because geographic variance in phenotypes of young stroke survivors is predominantly determined by overall ethnic group rather than nationality (35). Consistently, geographic variance seems not be limited to between-country comparisons. Our data on cardiovascular risk factors differ from previous studies of stroke patients in Saudi Arabia that reported on subgroups of young stroke patients (30, 31). In these studies, hypertension was the most prevalent risk factor, whereas in our cohort, dyslipidemia, as well diabetes and smoking, was more frequent than hypertension. However, this discrepancy might be explained in parts by the inclusion of hemorrhagic stroke patients in the two aforementioned investigations as these patients are more likely suffering from hypertension than ischemic stroke patients. Notably, a recent study in a Saudi Arabian cohort analyzed the risk factors of ischemic stroke in older adults and observed risk factor patterns similar to those of the two subgroups (35).

Our results of cerebrovascular risk factor assessment in the two age strata of young stroke patients were partially consistent with the results of previous international studies of ischemic stroke in young people of similar age (9, 1618). In an Australian study of ischemic stroke in the young, dyslipidemia, smoking, and hypertension were the most common risk factors (36). Although the study conducted analysis on two young age groups,15 to 42 years old (162 patients) and 43 to 50 years old (164 patients), the results were comparable among both groups. These observations were also similar to the results of the Helsinki Young Stroke Registry, which also analyzed two age groups, a younger group 15 to 44 years of age (n = 544) and an older group 45 to 49 years of age (n = 464) (3). Dyslipidemia was also the most common well-documented risk factor in both groups followed by smoking in the younger group, which was the third common risk factor in the older group after hypertension. By contrast, the European 15 Cities Young Stroke Study identified smoking as the most common risk factor (49%) among young stroke patients, followed by dyslipidemia (46%), which corresponds to a Greek study in young adults where smoking and dyslipidemia were the most frequent risk factors in both age groups (16, 37). In our study, diabetes was the 2nd most common risk factor, contrasting the aforementioned previous studies. The World Health Organization has reported that Saudi Arabia ranks 2nd highest in the Middle East and 7th in the world for the rate of diabetes, which might explain this discrepancy (38).

Small vessel occlusion was the most frequent etiology in our study, accounting for almost one-third of strokes, whereas ~one of five of our patients had cardioembolic causes, and 12.7% had large artery atherosclerosis. Altogether this observation is comparable with a previous study in a Jordanian population as well as retrospective analysis in a Saudi population of stroke patients (35, 39). Small vessel occlusion was found to be the most common etiology of ischemic stroke in a previous Kuwaiti study (40). By contrast, research on stroke epidemiology in Arabian Gulf countries showed that large artery atherosclerosis incidence was more frequent than small vessel occlusion (31, 41, 42). Similar to our cohort, stroke registries from Taiwan and Japan identified small vessel occlusion as the most common subtype followed by cardioembolism and large artery atherosclerosis (43, 44). Particularly in the registry from Japan, age-adjusted incidence rates in the group of ≤44 years of age were highest for small vessel occlusion, followed by large artery atherosclerosis and cardioembolism. This is also in line with our very young age strata, where small vessel occlusion constituted the most frequent stroke etiology. In an Australian study of ischemic stroke in young patients, the most frequent etiology in an older cohort aged 43 to 50 years old (n = 164 patients) was categorized as other determined etiology followed by cardioembolism, whereas in a younger cohort aged 15 to 42 years (n = 162), cardioembolism displayed the highest prevalence (36). In the Helsinki Young Stroke Registry, the most frequent etiology in the younger age group (15–44 years of age) was categorized as other determined etiology followed by undetermined etiology, whereas in the older age group (45–49 years of age), the most common etiology was small vessel occlusion (9). This observation differs from our results, in which the prevalence of cardioembolic cause was higher in our very young patients (≤40 years of age), but small vessel occlusion was most prevalent in our older strata (41–49 years of age). A case series of 394 young stroke patients in Rome yielded similar results (18). Cardioembolism was found in 34% of these patients, whereas small vessel occlusion was diagnosed in only 2.5%. A retrospective study of ischemic stroke in young adults over a period of 27 years in Spain found large artery atherosclerosis in 21% of patients, whereas cardioembolism accounted for only 17% of etiologies (17). We found a similarity between our study results and the Athens Young Stroke Registry, where small vessel occlusion (17.4%) was more frequent than cardioembolism (13.4%) in the older group (31–45 years of age, n = 205) (16). However, prevalence of cardioembolism was higher in the younger group (15–30 years of age, n = 48) with no evidence of small vessel occlusion. Our observations, viewed in conjunction with the aforementioned international research studies might suggest that in the studied Middle East and Asian regions, small vessel disease plays a more dominant role in the etiology of stroke in young individuals than in European and American populations. However, as recently pointed out in a global perspective on stroke in the young, a wide variety of possible underlying risk factors and etiologies need to be acknowledged, making it difficult to assess external validity of regional data (45).

In our cohort, the anterior circulation was by far more frequently affected (69.8%) than the posterior circulation (17.5%), whereas 12.7% of our population had a stroke in both vascular territories. This pattern is similar to previous Saudi studies results, as well-international studies of ischemic stroke in young adults (9, 19, 29, 31, 35, 46, 47). This observation was consistent among age strata in our cohort, as well as in previous populations of young stroke patients, such as the aforementioned Australian study of ischemic stroke in young patients and the Helsinki Young Stroke Registry (9, 36).

Our study is limited by its monocentric design. However, our data set derived from detailed cerebrovascular assessment and covered a 7-year observational period supporting internal validity and adding useful insight to complement the available information on the epidemiology of stroke in the young in the context of global geographic variance. While there is no clear age cutoff to discriminate stroke from stroke in the young, our observation of variable cerebrovascular phenotypes in two different age strata in a young stroke cohort highlights the need for comprehensive analysis of age-dependent cerebrovascular risk profiles and etiologies in young stroke patients. It is noteworthy that the age cutoff between pediatric and juvenile stroke displays a higher degree of agreement in the literature with individuals younger than 18 years considered pediatric. However, it remains questionable whether this age cutoff reflects age-related differences in the pathophys[i]iology of stroke. In research studies, a broader spectrum of age strata might be useful to study age-dependent differences in mechanisms of acute ischemic stroke. The knowledge deriving from this research might also help design tailored age-related strategies of diagnostic workup in young stroke patients that allow targeted assessment and avoidance of unnecessary procedures (48).

Our data support variability of patterns of cerebrovascular risk factors and stroke etiologies among regions and age groups in young stroke patients. Elaborating these differences may help formulate preventive measures by analyzing why certain populations have low prevalence in some risk factors. Nevertheless, studies that show similar distributions and frequencies of cerebrovascular risk factors underscore the need of global preventive protocols that also allow regional adaption to local epidemiological data.

Conclusion

Cerebrovascular risk profiles and stroke etiology patterns in our cohort of young stroke patients in a Saudi Arabian cohort differed from previous studies, in particular from those outside Asia and the Middle East, underscoring the need for comprehensive global data on geographic variance. This is especially important in currently understudied regions in developing countries because detailed epidemiological information on young stroke patients forms a basis for designing individualized prevention strategies. Apparently, these strategies might benefit from an age-dependent approach as very young stroke patients display different cerebrovascular risk profiles and etiologies than young to middle-aged stroke survivors.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics Statement

The studies involving human participants were reviewed and approved by Institutional Review Board of King Abdullah Medical City - IRB number: 18-485. Written informed consent from the participants' legal guardian/next of kin was not required to participate in this study in accordance with the national legislation and the institutional requirements.

Author Contributions

ME: conception, acquisition, analysis, and drafting the manuscript. AT and AS: analysis, interpretation, and revising the manuscript. EA, L-PP, JB, VP, and KB: interpretation and revising the manuscript. BI: design, interpretation, and revising the manuscript. TS: design, analysis, interpretation, and revising the manuscript. All authors contributed to the article and approved the submitted version.

Funding

Open Access funding was enabled by the Open Access Publication Funds of the SLUB/TU Dresden.

Conflict of Interest

TS received grants from the German Federal Ministry of Health, Kurt Goldstein Institute and German Parkinson's Association that were not related to this study and also received royalties from AstraZeneca for consulting and from Dresden International University for serving as program director and lecturer of the Master's Program in Clinical Research that were not related to this study.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Acknowledgments

We are grateful to Dr. Soha Almorsy for her guidance and Dr. Basem Aldeek for their advice on statistics. This work is part of a Master's thesis at Dresden International University.

References

1. Bonita R, Mendis S, Truelsen T, Bogousslavsky J, Toole J, Yatsu F. The global stroke initiative. Lancet Neurol. (2004) 3:391–3. doi: 10.1016/S1474-4422(04)00800-2

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Feigin VL. Stroke epidemiology in the developing world. Lancet. (2005) 365:2160–1. doi: 10.1016/S0140-6736(05)66755-4

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Schoenberg BS, Mellinger JF, Schoenberg DG. Cerebrovascular disease in infants and children: a study of incidence, clinical features, and survival. Neurology. (1978) 28:763–8. doi: 10.1212/WNL.28.8.763

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Lynch JK, Hirtz DG, DeVeber G, Nelson KB. Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics. (2002) 109:116–23. doi: 10.1542/peds.109.1.116

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Lynch JK. Cerebrovascular disorders in children. Curr Neurol Neurosci Rep. (2004) 4:129–38. doi: 10.1007/s11910-004-0027-3

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Fullerton HJ, Wu YW, Zhao S, Johnston SC. Risk of stroke in children: ethnic and gender disparities. Neurology. (2003) 61:189–94. doi: 10.1212/01.WNL.0000078894.79866.95

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Tsze DS, Valente JH. Pediatric stroke: a review. Emerg Med Int. (2011) 2011:734506. doi: 10.1155/2011/734506

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Pacheco JT, Siepmann T, Barlinn J, Winzer S, Penzlin AI, Puetz V, et al. Safety and efficacy of recanalization therapy in pediatric stroke: a systematic review and meta-analysis. Eur J Paediatr Neurol. (2018) 22:1035–41. doi: 10.1016/j.ejpn.2018.07.013

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Putaala J, Metso AJ, Metso TM, Konkola N, Kraemer Y, Haapaniemi E, et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke. (2009) 40:1195–203. doi: 10.1161/STROKEAHA.108.529883

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Maaijwee NA, Rutten-Jacobs LC, Schaapsmeerders P, van Dijk EJ, de Leeuw FE. Ischaemic stroke in young adults: risk factors and long-term consequences. Nat Rev Neurol. (2014) 10:315–25. doi: 10.1038/nrneurol.2014.72

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Rosengren A, Giang KW, Lappas G, Jern C, Torén K, Björck L. Twenty-four-year trends in the incidence of ischemic stroke in Sweden from 1987 to 2010. Stroke. (2013) 44:2388–93. doi: 10.1161/STROKEAHA.113.001170

PubMed Abstract | CrossRef Full Text | Google Scholar

12. George MG, Tong X, Kuklina EV, Labarthe DR. Trends in stroke hospitalizations and associated risk factors among children and young adults, 1995-2008. Ann Neurol. (2011) 70:713–21. doi: 10.1002/ana.22539

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Kissela BM, Khoury JC, Alwell K, Moomaw CJ, Woo D, Adeoye O, et al. Age at stroke: temporal trends in stroke incidence in a large, biracial population. Neurology. (2012) 79:1781–7. doi: 10.1212/WNL.0b013e318270401d

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Vangen-Lønne AM, Wilsgaard T, Johnsen SH, Carlsson M, Mathiesen EB. Time trends in incidence and case fatality of ischemic stroke: the tromsø study 1977-2010. Stroke. (2015) 46:1173–9. doi: 10.1161/STROKEAHA.114.008387

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Béjot Y, Daubail B, Jacquin A, Durier J, Osseby GV, Rouaud O, et al. Trends in the incidence of ischaemic stroke in young adults between 1985 and 2011: the Dijon Stroke Registry. J Neurol Neurosurg Psychiatry. (2014) 85:509–13. doi: 10.1136/jnnp-2013-306203

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Spengos K, Vemmos K. Risk factors, etiology, and outcome of first-ever ischemic stroke in young adults aged 15 to 45 - the Athens young stroke registry. Eur J Neurol. (2010) 17:1358–64. doi: 10.1111/j.1468-1331.2010.03065.x

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Varona JF, Guerra JM, Bermejo F, Molina JA, Gomez de. la Cámara A. Causes of ischemic stroke in young adults, and evolution of the etiological diagnosis over the long term. Eur Neurol. (2007) 57:212–8. doi: 10.1159/000099161

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Rasura M, Spalloni A, Ferrari M, De Castro S, Patella R, Lisi F, et al. A case series of young stroke in Rome. Eur J Neurol. (2006) 13:146–52. doi: 10.1111/j.1468-1331.2006.01159.x

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Kristensen B, Malm J, Carlberg B, Stegmayr B, Backman C, Fagerlund M, et al. Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in northern Sweden. Stroke. (1997) 28:1702–9. doi: 10.1161/01.STR.28.9.1702

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Nedeltchev K, der Maur TA, Georgiadis D, Arnold M, Caso V, Mattle HP, et al. Ischaemic stroke in young adults: predictors of outcome and recurrence. J Neurol Neurosurg Psychiatry. (2005) 76:191–5. doi: 10.1136/jnnp.2004.040543

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Chan MT, Nadareishvili ZG, Norris JW. Diagnostic strategies in young patients with ischemic stroke in Canada. Can J Neurol Sci. (2000) 27:120–4. doi: 10.1017/S0317167100052215

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Williams LS, Garg BP, Cohen M, Fleck JD, Biller J. Subtypes of ischemic stroke in children and young adults. Neurology. (1997) 49:1541–5. doi: 10.1212/WNL.49.6.1541

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Qureshi AI, Safdar K, Patel M, Janssen RS, Frankel MR. Stroke in young black patients. Risk factors, subtypes, and prognosis. Stroke. (1995) 26:1995–8. doi: 10.1161/01.STR.26.11.1995

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Adams HP Jr, Kappelle LJ, Biller J, Gordon DL, Love BB, Gomez F, et al. Ischemic stroke in young adults. Experience in 329 patients enrolled in the Iowa Registry of stroke in young adults. Arch Neurol. (1995) 52:491–5. doi: 10.1001/archneur.1995.00540290081021

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Siqueira Neto JI, Santos AC, Fabio SR, Sakamoto AC. Cerebral infarction in patients aged 15 to 40 years. Stroke. (1996) 27:2016–9. doi: 10.1161/01.STR.27.11.2016

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Lee TH, Hsu WC, Chen CJ, Chen ST. Etiologic study of young ischemic stroke in Taiwan. Stroke. (2002) 33:1950–5. doi: 10.1161/01.STR.0000021409.16314.16

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Lipska K, Sylaja PN, Sarma PS, Thankappan KR, Kutty VR, Vasan RS, et al. Risk factors for acute ischaemic stroke in young adults in South India. J Neurol Neurosurg Psychiatry. (2007) 78:959–63. doi: 10.1136/jnnp.2006.106831

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Kwon SU, Kim JS, Lee JH, Lee MC. Ischemic stroke in Korean young adults. Acta Neurol Scand. (2000) 101:19–24. doi: 10.1034/j.1600-0404.2000.00004.x

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Naess H, Nyland HI, Thomassen L, Aarseth J, Myhr KM. Etiology of and risk factors for cerebral infarction in young adults in western Norway: a population-based case-control study. Eur J Neurol. (2004) 11:25–30. doi: 10.1046/j.1351-5101.2003.00700.x

PubMed Abstract | CrossRef Full Text | Google Scholar

30. al-Rajeh S, Larbi EB, Bademosi O, Awada A, Yousef A, al-Freihi H, et al. Stroke register: experience from the eastern province of Saudi Arabia. Cerebrovasc Dis. (1998) 8:86–9. doi: 10.1159/000015823

PubMed Abstract | CrossRef Full Text | Google Scholar

31. al Rajeh S, Bademosi O, Ismail H, Awada A, Dawodu A, al-Freihi H, et al. A community survey of neurological disorders in Saudi Arabia: the Thugbah study. Neuroepidemiology. (1993) 12:164–78. doi: 10.1159/000110316

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. (1993) 24:35–41. doi: 10.1161/01.STR.24.1.35

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Schöberl F, Ringleb PA, Wakili R, Poli S, Wollenweber FA, Kellert L. Juvenile Stroke. Dtsch Arztebl Int. (2017) 114:527–34. doi: 10.3238/arztebl.2017.0527

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Leening MJ, Ferket BS, Steyerberg EW, Kavousi M, Deckers JW, Nieboer D, et al. Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study. BMJ. (2014) 349:g5992. doi: 10.1136/bmj.g5992

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Zafar A, Al-Khamis FA, Al-Bakr AI, Alsulaiman AA, Msmar AH. Risk factors and subtypes of acute ischemic stroke. A study at King Fahd Hospital of the University. Neurosciences (Riyadh). (2016) 21:246–51. doi: 10.17712/nsj.2016.3.20150731

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Phillips MC, Leyden JM, Chong WK, Kleinig T, Czapran P, Lee A, et al. Ischaemic stroke among young people aged 15 to 50 years in Adelaide, South Australia. Med J Aust. (2011) 195:610–4. doi: 10.5694/mja11.10558

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Putaala J, Yesilot N, Waje-Andreassen U, Pitkäniemi J, Vassilopoulou S, Nardi K, et al. Demographic and geographic vascular risk factor differences in European young adults with ischemic stroke: the 15 cities young stroke study. Stroke. (2012) 43:2624–30. doi: 10.1161/STROKEAHA.112.662866

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Al Dawish MA, Robert AA, Braham R, Al Hayek AA, Al Saeed A, Ahmed RA, et al. Diabetes mellitus in Saudi Arabia: a review of the recent literature. Curr Diabetes Rev. (2016) 12:359–68. doi: 10.2174/1573399811666150724095130

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Bahou Y, Hamid H, Raqab MZ. Ischemic stroke in Jordan 2000 to 2002: a two-year, hospital-based study. J Stroke Cerebrovasc Dis. (2004) 13:81–4. doi: 10.1016/j.jstrokecerebrovasdis.2004.02.004

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Al-Shammri S, Shahid Z, Ghali A, Mehndiratta MM, Swaminathan TR, Chadha G, et al. Risk factors, subtypes and outcome of ischaemic stroke in Kuwait–a hospital-based study. Med Princ Pract. (2003) 12:218–23. doi: 10.1159/000072287

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Deleu D, Inshasi J, Akhtar N, Ali J, Vurgese T, Ali S, et al. Risk factors, management and outcome of subtypes of ischemic stroke: a stroke registry from the Arabian Gulf. J Neurol Sci. (2011) 300:142–7. doi: 10.1016/j.jns.2010.08.023

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Abdul-Ghaffar NU, el-Sonbaty MR, el-Din Abdul-Baky MS, Marafie AA, al-Said AM. Stroke in Kuwait: a three-year prospective study. Neuroepidemiology. (1997) 16:40–7. doi: 10.1159/000109669

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Yip PK, Jeng JS, Lee TK, Chang YC, Huang ZS, Ng SK, et al. Subtypes of ischemic stroke. A hospital-based stroke registry in Taiwan (SCAN-IV). Stroke. (1997) 28:2507–12. doi: 10.1161/01.STR.28.12.2507

PubMed Abstract | CrossRef Full Text | Google Scholar

44. Turin TC, Kita Y, Rumana N, Nakamura Y, Takashima N, Ichikawa M, et al. Ischemic stroke subtypes in a Japanese population: Takashima stroke registry, 1988-2004. Stroke. (2010) 41:1871–6. doi: 10.1161/STROKEAHA.110.581033

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Boot E, Ekker MS, Putaala J, Kittner S, De Leeuw FE, Tuladhar AM. Ischaemic stroke in young adults: a global perspective. J Neurol Neurosurg Psychiatry. (2020) 91:411–7. doi: 10.1136/jnnp-2019-322424

PubMed Abstract | CrossRef Full Text | Google Scholar

46. El Sayed MM, Adeuja AO, El-Nahrawy E, Olaish MA. Characteristics of stroke in Hofuf, Saudi Arabia. Ann Saudi Med. (1999) 19:27–31. doi: 10.5144/0256-4947.1999.27

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Yaqub BA, Shamena AR, Kolawole TM, Patel PJ. Cerebrovascular disease in Saudi Arabia. Stroke. (1991) 22:1173–6. doi: 10.1161/01.STR.22.9.1173

PubMed Abstract | CrossRef Full Text | Google Scholar

48. Prakapenia A, Barlinn K, Pallesen LP, Köhler A, Siepmann T, Winzer S, et al. Low diagnostic yield of routine cerebrospinal fluid analysis in juvenile stroke. Front Neurol. (2018) 9:694. doi: 10.3389/fneur.2018.00694

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: stroke, ischemic stroke, stroke in young, Saudi Arabia, risk factors, juvenile, infarction, ischemia

Citation: Eltemamy MA, Tamayo A, Altarsha E, Sedghi A, Pallesen L-P, Barlinn J, Puetz V, Illigens BM-W, Barlinn K and Siepmann T (2021) Cerebrovascular Risk Profiles in a Saudi Arabian Cohort of Young Stroke Patients. Front. Neurol. 12:736818. doi: 10.3389/fneur.2021.736818

Received: 05 July 2021; Accepted: 05 October 2021;
Published: 12 November 2021.

Edited by:

Tapas Banerjee, National Neurosciences Centre, India

Reviewed by:

Oleg Chernyshev, Louisiana State University Health Shreveport, United States
Juan Moisés De La Serna, Universidad Internacional De La Rioja, Spain

Copyright © 2021 Eltemamy, Tamayo, Altarsha, Sedghi, Pallesen, Barlinn, Puetz, Illigens, Barlinn and Siepmann. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Timo Siepmann, timo.siepmann@ukdd.de

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.